Major Force in the Yellow Fever Vaccine Market 2025: Growth Of The Yellow Fever Vaccine Market Due To Increasing International Travel

"How Will the Yellow Fever Vaccine Market Grow, and What Is the Projected Market Size?
Recently, there has been a substantial growth in the yellow fever vaccine market. An increase from $4.54 billion in 2024 to $4.79 billion in 2025 is projected, marking a compound annual growth rate (CAGR) of 5.4%. The significant growth during the historical period can be accredited to the start of global vaccination drives, execution of worldwide health guidelines, widespread vaccine distribution initiatives, and progress in vaccine production technology.

In the coming years, the market size of the yellow fever vaccine is projected to witness robust growth. The market is forecasted to reach $5.84 billion in 2029 with a compound annual growth rate (CAGR) of 5.1%. This growth during the projection period can be credited to factors such as scaled up partnerships and collaboration, inclusion with regular vaccination routines, enhanced surveillance and monitoring, greater participation from the private sector, and the implementation of digital technologies for monitoring vaccines. Key trends during the forecast period encompass the diversification of vaccine formats, readiness for pandemics, alterations in regulations, advancements in healthcare facilities, as well as consumer education and awareness.

What Key Elements Are Boosting Growth in the Yellow Fever Vaccine Market?
The yellow fever vaccine market is predicted to be propelled by the escalating trend of international travel. The term international travel is used to describe the crossing of national borders by individuals for reasons including tourism, personal motives, or business. This kind of travel has seen a rise due to factors like greater worldwide connectivity, economic upliftment, and the easing of travel restrictions in the post-pandemic era. Immunization against yellow fever is either mandatory or recommended for tourists traveling to areas notorious for the disease, as it aids in preventing the infection and adheres to international health norms. To illustrate, in 2023, as reported by the World Tourism Organization, a Spain-based agency, there were 1.286 billion international sightseers (overnight visitors) at the global level, up from 960 million in 2022. This indicates an uplift of 326 million global travelers from 2022 to 2023. Therefore, the surge in international travel can be taken as a driver for the expansion of the yellow fever vaccine market.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=17297&type=smp

Who Are the Major Industry Players Fueling Yellow Fever Vaccine Market Expansion?
Major companies operating in the yellow fever vaccine market are Merck and Co Inc., Sanofi S.A., GSK plc, Takeda Pharmaceutical Company, Lonza Group Ag, WuXi Biologics, Novavax Inc., Beijing Tiantan Biological, Bavarian Nordic A/S, Valneva SE, Biological E. Limited, Bio-Manguinhos, Instituto Butantan, Bio Farma, Panacea Biotec, Biovac, Institut Pasteur de Dakar, Ology Bioservices, Gavi, Wuhan Institute of Biological Products, PnuVax Incorporated, iBio Inc.

Which Key Developments Are Influencing the Yellow Fever Vaccine Market?
Major firms in the yellow fever vaccine market are striving to create more efficient vaccines for the next generation. To fulfill the growing global demand, these include advanced T-cell booster vaccines. These T-cell vaccines are geared towards amplifying the immune system's memory T-cell responses, providing extended and stronger immunity against distinct pathogens. In a pertinent example from April 2022, Emergex Vaccines Holding Limited, a biotech company based in the UK, collaborated with ATCC, a non-profit US-based organization offering reference microorganisms, cell lines, and other research and development materials, to launch CD8+ T-cell adaptive vaccines. These vaccines, targeted specifically for yellow fever, are designed to provoke a strong cytotoxic T-cell reaction, crucial for spotting and eradicating cells infected with the virus. They enable the creation of memory CD8+ T-cells, leading to durable and potent immunity. The emphasis is on the cellular immune response rather than just antibody creation, thereby offering broad protection against yellow fever and potentially improving effectiveness among people with varied immune profiles.

How Is the Segmentation of the Yellow Fever Vaccine Market Defined?
The yellow fever vaccine market covered in this report is segmented -

1) By Product: Powder, Liquid
2) By Treatment Type: Pain Management Drugs, Oral Rehydration
3) By Application: Routine Immunization, Travelers, Other Applications
4) By End-User: Hospitals, Diagnostic Centers, Point Of Care Centers, Other End Users

Subsegments:
1) By Powder: Lyophilized Powder For Reconstitution, Freeze-Dried Powder For Reconstitution
2) By Liquid: Ready-To-Use Liquid Vaccine, Liquid Vaccine In Pre-Filled Syringes

Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/yellow-fever-vaccine-global-market-report

What Is the Leading Region in the Yellow Fever Vaccine Market?
North America was the largest region in the yellow fever vaccine market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the yellow fever vaccine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Is Covered In The Yellow Fever Vaccine Global Market Report?

- Market Size Analysis: Analyze the Yellow Fever Vaccine Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Yellow Fever Vaccine Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Yellow Fever Vaccine Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Yellow Fever Vaccine Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=17297

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.